wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28082793-FFEB707B-6689-4837-80A2-78184F6D7197
Q28082793-FFEB707B-6689-4837-80A2-78184F6D7197
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082793-FFEB707B-6689-4837-80A2-78184F6D7197
Receptor tyrosine kinases: Characterisation, mechanism of action and therapeutic interests for bone cancers
P2860
Q28082793-FFEB707B-6689-4837-80A2-78184F6D7197
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28082793-FFEB707B-6689-4837-80A2-78184F6D7197
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c7190cce64877cfcd971c90b31746b782a001c7b
P2860
Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial.